Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dopamine transporter (DAT) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease

1 Feb 1996

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Neurodegenerative Diseases
Share to Neurological disorders and treatments
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 9011752
DOI: 10.1016/0169-328x(95)00278-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dopamine transporter (DAT) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's diseasePMID 9011752Read ↗

Transcriptome responses to reduced dopamine in the Substantia Nigra Pars Compacta reveals a potential protective role for dopamineSemantic proximity Read ↗

Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's diseaseSemantic proximity Read ↗

Proportion and distribution of neurotransmitter-defined cell types in the ventral tegmental area and substantia nigra pars compactaSemantic proximity Read ↗

Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson’s diseaseSemantic proximity Read ↗

Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson’s disease patients with impulse control disordersSemantic proximity Read ↗

Dynamic control of the dopamine transporter in neurotransmission and homeostasisSemantic proximity Read ↗

Analysis of Gene Expression in Parkinson's Disease: Possible Involvement of Neurotrophic Support and Axon Guidance in Dopaminergic Cell DeathSemantic proximity Read ↗

Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson’s diseaseSemantic proximity Read ↗

Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.Semantic proximity Read ↗

Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotypeSemantic proximity Read ↗

Dopamine transporter: basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism.Semantic proximity Read ↗

Rit2 silencing in dopamine neurons drives a Parkinsonian phenotypeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.